Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Prognostic Impact of Early GNRI Sustainability in Metastatic Urothelial Carcinoma Receiving Pembrolizumab

YOSUKE SUGIYAMA, TAKU NAIKI, TOSHIHARU MORIKAWA, KUNIHIRO ODAGIRI, YOSHIHISA MIMURA, YOSHIHIKO TASAKI, NOBUHIKO SHIMIZU, TAKASHI NAGAI, TOSHIKI ETANI, DAIKI ISHIKAWA, MISATO TOMITA, MOEKO IIDA, NANAMI ITO, YUKA KIMURA, YUJI HOTTA, TAKAHIRO YASUI and YOKO FURUKAWA-HIBI
Anticancer Research April 2026, 46 (4) 2187-2198; DOI: https://doi.org/10.21873/anticanres.18107
YOSUKE SUGIYAMA
1Department of Pharmacy, Nagoya City University Hospital, Nagoya, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKU NAIKI
2Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan;
3Department of Urology, Nagoya West Medical Center, Nagoya, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: naiki{at}med.nagoya-cu.ac.jp
TOSHIHARU MORIKAWA
2Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KUNIHIRO ODAGIRI
1Department of Pharmacy, Nagoya City University Hospital, Nagoya, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YOSHIHISA MIMURA
1Department of Pharmacy, Nagoya City University Hospital, Nagoya, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YOSHIHIKO TASAKI
1Department of Pharmacy, Nagoya City University Hospital, Nagoya, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NOBUHIKO SHIMIZU
2Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKASHI NAGAI
2Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOSHIKI ETANI
2Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DAIKI ISHIKAWA
2Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MISATO TOMITA
1Department of Pharmacy, Nagoya City University Hospital, Nagoya, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MOEKO IIDA
1Department of Pharmacy, Nagoya City University Hospital, Nagoya, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NANAMI ITO
1Department of Pharmacy, Nagoya City University Hospital, Nagoya, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUKA KIMURA
1Department of Pharmacy, Nagoya City University Hospital, Nagoya, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUJI HOTTA
1Department of Pharmacy, Nagoya City University Hospital, Nagoya, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKAHIRO YASUI
2Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YOKO FURUKAWA-HIBI
1Department of Pharmacy, Nagoya City University Hospital, Nagoya, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

patientACCESS

patientACCESS - Patients desiring access to articles
PreviousNext
Back to top

In this issue

Anticancer Research: 46 (4)
Anticancer Research
Vol. 46, Issue 4
April 2026
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Ed Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prognostic Impact of Early GNRI Sustainability in Metastatic Urothelial Carcinoma Receiving Pembrolizumab
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
8 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Prognostic Impact of Early GNRI Sustainability in Metastatic Urothelial Carcinoma Receiving Pembrolizumab
YOSUKE SUGIYAMA, TAKU NAIKI, TOSHIHARU MORIKAWA, KUNIHIRO ODAGIRI, YOSHIHISA MIMURA, YOSHIHIKO TASAKI, NOBUHIKO SHIMIZU, TAKASHI NAGAI, TOSHIKI ETANI, DAIKI ISHIKAWA, MISATO TOMITA, MOEKO IIDA, NANAMI ITO, YUKA KIMURA, YUJI HOTTA, TAKAHIRO YASUI, YOKO FURUKAWA-HIBI
Anticancer Research Apr 2026, 46 (4) 2187-2198; DOI: 10.21873/anticanres.18107

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Prognostic Impact of Early GNRI Sustainability in Metastatic Urothelial Carcinoma Receiving Pembrolizumab
YOSUKE SUGIYAMA, TAKU NAIKI, TOSHIHARU MORIKAWA, KUNIHIRO ODAGIRI, YOSHIHISA MIMURA, YOSHIHIKO TASAKI, NOBUHIKO SHIMIZU, TAKASHI NAGAI, TOSHIKI ETANI, DAIKI ISHIKAWA, MISATO TOMITA, MOEKO IIDA, NANAMI ITO, YUKA KIMURA, YUJI HOTTA, TAKAHIRO YASUI, YOKO FURUKAWA-HIBI
Anticancer Research Apr 2026, 46 (4) 2187-2198; DOI: 10.21873/anticanres.18107
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Patients and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Identification of Risk Factors for the Local Recurrence of Hepatocellular Carcinoma Post-radiofrequency Ablation
  • Practical Implementation and Validation of Geriatric Assessment in Older Adults With Esophageal Cancer
  • Laparotomy After Total Pelvic Exenteration: Current Status and Techniques for Ileal Conduit Preservation
Show more Clinical Studies

Keywords

  • geriatric nutritional risk index
  • metastatic urothelial carcinoma
  • pembrolizumab
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire